Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks (DUC)
Status
Conditions
Treatments
Details and patient eligibility
About
The overall objective of the present study is to examine the effects of delayed umbilical cord clamping in preterm infants on neonatal outcomes using a prospective randomized controlled trial comparing immediate cord clamping (standard at present) with delayed cord clamping.
Our specific aim is to determine if a 30 to 45 second delay in umbilical cord clamping improves neonatal outcome as assessed by a composite of intraventricular hemorrhage and late onset sepsis in preterm infants born between 24 and 32 weeks gestation. Secondary outcomes to be examined include improvements in the following: 1) lung function as assessed by oxygen dependency at 36 weeks corrected gestational age (CGA), 2) cardiovascular function as assessed by the need for volume expansion, inotropes, or clinically suspected PDA requiring intervention prior to discharge home, and 3) anemia as assessed by initial hemoglobin, need for transfusion during stay in the NICU, and number of transfusions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Women in labour or with a plan for delivery at a gestational age between 24 0/7 to 32 0/7 weeks gestation.
- Singleton pregnancy (Note: if pregnancy was a multiple gestation but demised occurred prior to 13 weeks, these patients can be included in study).
Exclusion criteria
- Moderate to life threatening fetal anomalies
- Multiple live gestations at birth (e.g. twins, triplets, etc)
- Intrauterine fetal demise
- Previous participation
- Stem cell collection
Trial design
Primary purpose
Allocation
Interventional model
Masking
296 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Kelly Chu, MD; Kellie E. Murphy, MD MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal